Provided by Tiger Trade Technology Pte. Ltd.

Aktis Oncology

18.52
0.0000
Pre-market: 18.670.1500+0.81%06:38 EDT
Volume:337.99K
Turnover:6.20M
Market Cap:1.02B
PE:-13.54
High:18.82
Open:18.75
Low:17.93
Close:18.52
52wk High:34.19
52wk Low:14.72
Shares:55.28M
Float Shares:17.65M
Volume Ratio:1.11
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3680
EPS(LYR):-78.3394
ROE:-29.45%
ROA:-15.79%
PB:2.11
PE(LYR):-0.24

Loading ...

May 20, 2024

Major Issues Report

Form 8-K - Current report
May 18, 2024

Correspondence

Form CORRESP - Correspondence
May 13, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 29, 2024

Major Issues Report

Form 8-K - Current report
Jan 24, 2024

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 27, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Major Issues Report

Form 8-K - Current report